2025
SJR Q1
JCR Q4 · 0,3
ESCI
Journal detail
GaBI Journal
- Publisher
- Pro Pharma Communications International
- Country
- Belgium · Western Europe
- Type
- journal
- ISSN
-
2033640320336772
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,224
- Quartile Q1
- H-Index 16
- Cites/doc 0,36
- Docs (3y) 72
- Cites (3y) 28
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,3
- 5Y JIF 0,4
- JCI 0,05
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Drug Guides Q1
- Pharmacy Q3
Areas
- Health Professions
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q4 | 0,224 | 0,3 | 0,4 | 0,05 | Q4 | 16 |
| 2024 | Q3 | Q4 | 0,15 | 0,2 | 0,5 | 0,07 | Q4 | 16 |
| 2023 | Q3 | Q4 | 0,163 | 0,3 | 0,6 | 0,2 | Q4 | 16 |
| 2022 | Q3 | — | 0,174 | 0,5 | 0,7 | 0,27 | Q4 | 16 |
| 2021 | Q3 | — | 0,153 | — | — | — | — | 16 |
| 2020 | Q2 | — | 0,217 | — | — | 0,38 | Q4 | 16 |
| 2019 | Q2 | — | 0,167 | — | — | — | — | 16 |
| 2017 | Q1 | — | 0,479 | — | — | — | — | 16 |
| 2016 | Q1 | — | 0,399 | — | — | — | — | 16 |
| 2015 | Q1 | — | 0,413 | — | — | — | — | 16 |
| 2014 | — | — | — | — | — | — | — | 16 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | ESCI | Q4 | Q4 | 351/356 |
| 2024 | PHARMACOLOGY & PHARMACY | ESCI | Q4 | Q4 | 345/352 |
| 2023 | PHARMACOLOGY & PHARMACY | ESCI | Q4 | Q4 | 344/354 |
| 2022 | PHARMACOLOGY & PHARMACY | ESCI | — | Q4 | — |
| 2020 | PHARMACOLOGY & PHARMACY | ESCI | — | Q4 | — |